Esophageal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma [Phase 2]
A Phase 2 clinical trial evaluating liquid nitrogen spray cryotherapy before neoadjuvant systemic therapy for esophageal adenocarcinoma; the…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: Survey Study on Barrett's Esophagus Screening
A completed survey study from the University of Colorado, Denver, evaluated screening for Barrett's esophagus in individuals with gastroesop…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers [NA]
A UCSF-led clinical trial is evaluating radiation therapy for metastatic gastrointestinal cancers, and the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Endoscopic Radiofrequency Ablation Versus Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus [NA]
A completed clinical trial comparing endoscopic radiofrequency ablation with hybrid argon plasma coagulation for Barrett's esophagus.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: "Less-is-more in Barrett-surveillance" Care Evaluation of Barrett's Patients With Low-Risk in Whom Endoscopic Surveillance is Stopped. The BLISS Project.
An Amsterdam-based study (BLISS Project) is evaluating whether endoscopic surveillance can be stopped in low-risk Barrett's esophagus patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers [Phase 2]
Phase 2 trial evaluating tucatinib plus trastuzumab with oxaliplatin-based chemotherapy or pembrolizumab-containing regimens for HER2-positi…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Evaluation of Seismocardiography(SCG) for Assessing Fitness and Predicting Outcomes in Oesophageal Cancer Surgery
The document describes a non-recruiting clinical trial evaluating seismocardiography to assess fitness and predict outcomes in esophageal ca…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer [Phase 1, Phase 2]
A phase 1/2 trial is evaluating durvalumab and tremelimumab with chemoradiation before surgery for esophageal and gastroesophageal junction …
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 clinical trial update evaluating chemoradiation with pembrolizumab, followed by pembrolizumab and lenvatinib before surgery for no…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma [Phase 2]
Phase 2 clinical trial update on the Ad5.F35-hGCC-PADRE cancer vaccine for pancreatic, colorectal, gastric, and esophageal adenocarcinomas; …
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Outcomes of a Single Chest Drain vs Two Drains [NA]
A clinical trial comparing single chest drain versus two drains in patients with pleural effusion and esophageal cancer-related complication…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
A Case Western Reserve University-led study aims to identify genetic determinants of Barrett's Esophagus and esophageal adenocarcinoma and i…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy [Phase 2]
A Phase 2 clinical trial is evaluating metformin as a metabolic intervention to improve response to neoadjuvant chemoradiotherapy in esophag…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) [Phase 2]
This is a Phase 2 master protocol evaluating SAR444245 in combination with other anticancer therapies for several gastrointestinal cancers; …
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: CLUE: CLinical Utility Study of EsoGuard [NA]
The CLUE study evaluating the clinical utility of EsoGuard for Barrett's esophagus and related conditions has completed.
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial [Phase 2]
A Phase 2 maintenance therapy trial for oesophago-gastric cancer is active but not recruiting, focusing on esophageal, gastroesophageal junc…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers [Phase 1]
Phase 1 trial updating on the addition of Adavosertib to radiation therapy in patients with incurable esophageal and gastroesophageal juncti…
-
CLINICAL_TRIALS withdrawal · 2025-06-08Clinical Trial Update: Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma
A clinical trial evaluating circulating tumor DNA in locally advanced esophageal and gastroesophageal junction adenocarcinoma has been withd…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery [Phase 1]
Phase 1 trial evaluating the addition of Telomelysin to chemoradiation for patients with advanced esophageal or gastroesophageal junction ad…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
This update notes the completion of a clinical trial investigating the roles of the microbiome, bile acids, and Notch signaling in Barrett's…
-
CLINICAL_TRIALS trial_result · 2025-03-31Clinical Trial Update: A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer [Phase 2, Phase 3]
A completed Phase 2/3 study evaluating nimotuzumab in combination with chemoradiation for locally advanced esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma [NA]
Clinical trial OPPOSITE, studying outcome prediction of systemic treatment in esophagogastric carcinoma, has completed. The sponsor is Unive…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors [Phase 2]
Phase 2 study evaluating the efficacy of tislelizumab and spartalizumab across multiple cancers with PD-1 high mRNA expression; the trial is…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating the TGF-beta receptor I inhibitor Vactosertib in combination with standard-of-care chemoradiotherapy for locally ad…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery
A longitudinal biomarker study in patients undergoing esophageal/gastric cancer surgery. Imperial College London is recruiting to profile bi…